Delay of generics' license will hurt pharmaceutical sector

The government's plan to deny a local pharmaceutical company the license to sell generic drugs for at least two years under the proposed revision of the Pharmaceutical Affairs Law stirred heated debate in a government-private discussion on October 30.

The delay of generics' launching will be a big blow to Korean companies that rely much of the revenue on the sales of generic drugs, and also ...